Delayed organising pneumonia in an immunocompromised host after a mild COVID-19 infection.
COVID-19
Respiratory medicine
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
16 May 2023
16 May 2023
Historique:
medline:
18
5
2023
pubmed:
17
5
2023
entrez:
16
5
2023
Statut:
epublish
Résumé
Organising pneumonia after a mild COVID-19 infection has been increasingly reported and poses a diagnostic challenge to physicians especially in immunocompromised patients. We report a patient with a background of lymphoma in remission on rituximab who presented with prolonged and persistent fever after recovering from a mild COVID-19 infection. The initial workup showed bilateral lower zone lung consolidation; however, the infective and autoimmune workup were unremarkable. Subsequently, a bronchoscopy with transbronchial lung biopsy confirmed the diagnosis of organising pneumonia. A tapering glucocorticoid regimen was commenced with prompt resolution of the patient's clinical symptoms, and subsequent resolution of biochemical markers and radiological lung changes 3 months later. This case highlights the importance of early recognition of the diagnosis of organising pneumonia in immunocompromised populations after a mild COVID-19 infection as it shows promising response to glucocorticoid therapy.
Identifiants
pubmed: 37192779
pii: 16/5/e254737
doi: 10.1136/bcr-2023-254737
pmc: PMC10193096
pii:
doi:
Substances chimiques
Glucocorticoids
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Front Oncol. 2020 Sep 02;10:1578
pubmed: 32984017
N Engl J Med. 2020 Dec 24;383(26):2586-2588
pubmed: 33259154
BMJ Case Rep. 2021 Oct 29;14(10):
pubmed: 34716149
Respirol Case Rep. 2022 Mar 29;10(5):e0944
pubmed: 35386579
Antimicrob Resist Infect Control. 2022 Feb 5;11(1):28
pubmed: 35123573
Medicina (Kaunas). 2021 Mar 18;57(3):
pubmed: 33803690
J Med Virol. 2022 Jan;94(1):417-423
pubmed: 34581458
Thorax. 2000 Apr;55(4):318-28
pubmed: 10722773
Leuk Lymphoma. 2008 Sep;49(9):1778-83
pubmed: 18798110
Lancet Oncol. 2020 Oct;21(10):1309-1316
pubmed: 32853557
J Infect. 2021 Oct;83(4):496-522
pubmed: 34217780
Clin Microbiol Infect. 2021 Jan;27(1):89-95
pubmed: 32979574
Pharmaceuticals (Basel). 2022 Dec 16;15(12):
pubmed: 36559025
Thorax. 2008 Sep;63 Suppl 5:v1-58
pubmed: 18757459
PLoS One. 2017 Sep 25;12(9):e0184739
pubmed: 28945804
Open Forum Infect Dis. 2021 May 20;8(6):ofab164
pubmed: 34189164
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
JAMA. 2021 May 25;325(20):2033-2035
pubmed: 33950236
Thorax. 2021 Feb;76(2):201-204
pubmed: 33177230
Cureus. 2022 Jun 23;14(6):e26230
pubmed: 35898367
Eur Respir J. 2000 Feb;15(2):373-81
pubmed: 10706507
Ann Hematol. 2021 Nov;100(11):2805-2812
pubmed: 34549309